NCT06168006 Exercise Training Using an App on Physical Cardiovascular Function Individuals With Post-covid-19 Syndrome
| NCT ID | NCT06168006 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nove de Julho |
| Condition | Post-Acute COVID-19 Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-03-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to assess the effect of a physical exercise program via a mobile application on functional parameters in individuals with post-COVID-19 syndrome. This is a clinical trial involving 60 individuals with post-COVID syndrome who will be randomly assigned to either a control group (physical activity guideline) or an experimental group (app-based training).
Eligibility Criteria
Inclusion Criteria: * Laboratory diagnosis of COVID-19 * Fatigue ≥ 8 points on the Chalder Scale and/or dyspnea 2-4 on the Modified Medical Research Council * Have access to a smartphone * Have no contraindications for exercise practice * Have ability to sit and stand and maintain balance while standing * Have preserved cognitive function * Have no risk of falls according to the Morse Fall Scale
Contact & Investigator
Fernanda Corrêa, PhD
PRINCIPAL INVESTIGATOR
University of Nove de Julho
Frequently Asked Questions
Who can join the NCT06168006 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post-Acute COVID-19 Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06168006 currently recruiting?
Yes, NCT06168006 is actively recruiting participants. Contact the research team at raphaelritti@gmail.com for enrollment information.
Where is the NCT06168006 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT06168006 clinical trial?
NCT06168006 is sponsored by University of Nove de Julho. The principal investigator is Fernanda Corrêa, PhD at University of Nove de Julho. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.